LIA
WST icon

LS Investment Advisors’s West Pharmaceutical WST Stock Holding History

LS Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,887
Closed -$4.48M – 735
2021
Q1 		$4.48M Buy
15,887
+10,134
+176% +$2.9M 0.25% 107
2020
Q4 		$1.63M Buy
5,753
+386
+7% +$108K 0.09% 198
2020
Q3 		$1.48M Buy
5,367
+2,882
+116% +$763K 0.08% 202
2020
Q2 		$565K Sell
2,485
-1,985
-44% -$390K 0.04% 338
2020
Q1 		$681K Sell
4,470
-727
-14% -$112K 0.05% 285
2019
Q4 		$781K Buy
5,197
+1,288
+33% +$188K 0.04% 354
2019
Q3 		$554K Sell
3,909
-28
-0.7% -$3.85K 0.03% 422
2019
Q2 		$493K Sell
3,937
-342
-8% -$40.4K 0.03% 463
2019
Q1 		$472K Sell
4,279
-142
-3% -$14.8K 0.03% 480
2018
Q4 		$433K Buy
4,421
+13
+0.3% +$1.41K 0.03% 462
2018
Q3 		$544K Sell
4,408
-73
-2% -$8.19K 0.03% 463
2018
Q2 		$445K Buy
4,481
+62
+1% +$5.71K 0.03% 545
2018
Q1 		$390K Sell
4,419
-407
-8% -$38.1K 0.02% 589
2017
Q4 		$476K Sell
4,826
-1,154
-19% -$113K 0.03% 516
2017
Q3 		$576K Sell
5,980
-205
-3% -$18.5K 0.03% 453
2017
Q2 		$585K Buy
6,185
+983
+19% +$90.4K 0.04% 430
2017
Q1 		$425K Sell
5,202
-101
-2% -$8.45K 0.03% 529
2016
Q4 		$450K Buy
5,303
+135
+3% +$10.6K 0.03% 446
2016
Q3 		$385K Buy
5,168
+100
+2% +$7.94K 0.03% 474
2016
Q2 		$385K Buy
5,068
+2,190
+76% +$159K 0.03% 517
2016
Q1 		$200K Buy
2,878
+225
+8% +$13.5K 0.01% 638
2015
Q4 		$160K Hold
2,653
– – 0.01% 695
2015
Q3 		$144K Sell
2,653
-74
-3% -$4.31K 0.01% 714
2015
Q2 		$158K Buy
+2,727
New +$152K 0.01% 687

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

LS Investment Advisors's WST Position: Q2 2021 in Review

LS Investment Advisors sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 15,887 shares — an estimated $4.48M sold.

LS Investment Advisors first reported a position in WST in Q2 2015 and held it in 24 quarters. The position peaked at $4.48M in Q1 2021. 639 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • LS Investment Advisors reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 15,887 West Pharmaceutical shares in Q2 2021, an estimated $4.48M.
  • LS Investment Advisors first reported a position in West Pharmaceutical in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's West Pharmaceutical position peaked at $4.48M in Q1 2021.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.